Novo Nordisk’s shares dropped 6.7% in Denmark after the company’s Wegovy weight-loss drug missed sales expectations as a result of the bigger discounts offered to U.S. buyers.

prologu5
08/08/2024

Wall Street Journal

Novo Nordisk’s shares dropped 6.7% in Denmark after the company’s Wegovy weight-loss drug missed sales expectations as a result of the bigger discounts offered to U.S. buyers.

https://www.wsj.com/health/pharma/wegovy-maker-novo-nordisk-lifts-sales-guidance-as-weight-loss-drug-demand-continues-to-surge-c5f2b4ed